| Group N (n = 196) | Group P (n = 205) | P-value |
---|---|---|---|
POD, n (%) | 38(19.39%) | 43(20.98%) | 0.692 |
POD duration n, (%) | Â | Â | 0.928 |
 Non-POD n, (%) | 158(80.61%) | 162(79.02%) |  |
 0 to 6 h n, (%) | 22(11.22%) | 26(12.68%) |  |
 6 to 12 h n, (%) | 9(4.59%) | 11(5.37%) |  |
 > 12 h n, (%) | 7(3.57%) | 6(2.93%) |  |
Postoperative MDAS score (point, \(\overline x\) ± s) | 8.17 ± 3.44 | 8.36 ± 3.37 | 0.571 |
Postoperative 24 h NRS score (point, \(\overline x\) ± s) | 1.98 ± 1.29 | 2.06 ± 1.22 | 0.505 |
Abnormal muscle weakness, n (%) | 0(0%) | 0(0%) | Â |
PONV, n (%) | 24(12.24%) | 22(10.73%) | 0.635 |
Gastrointestinal complications, n (%) | 35(17.86%) | 48(23.41%) | 0.170 |
Wound bleeding and infection, n (%) | 13(6.63%) | 17(8.29%) | 0.528 |
POPCs, n (%) | 42(21.43%) | 63(30.73%) | 0.034* |
Cardiac complications, n (%) | 3(1.53%) | 2(0.98%) | 0.679 |
Cerebrovascular complications, n (%) | 1(0.51%) | 2(0.98%) | 1.000 |
Postoperative hospital stay (day, \(\overline x\) ± s) | 12.44 ± 2.78 | 12.54 ± 2.50 | 0.726 |
Mortality in 6Â months, n (%) | 3(1.53%) | 4(1.96%) | 1.000 |